← Back to Search

Palliative Care

Palliative Care for Multiple Myeloma

N/A

Waitlist Available

Led By Renato Samala, MD

Research Sponsored by Case Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Have an ECOG performance status of 0, 1, 2 or 3

Must be within eight weeks of being diagnosed with symptomatic MM based on current diagnostic criteria

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months, 6 months, 9 months and 12 months

Awards & highlights

Study Summary

This trial is testing whether getting palliative care early on (alongside usual cancer care) can help people with newly diagnosed multiple myeloma.

Who is the study for?

This trial is for English-speaking individuals recently diagnosed with symptomatic Multiple Myeloma, within eight weeks. They should be able to perform daily activities with varying degrees of assistance (ECOG status 0-3) and must be receiving care at a Cleveland Clinic facility. Those who have already seen a Palliative Care provider or require immediate hospice care cannot participate.Check my eligibility

What is being tested?

The study is examining the impact of early Palliative Care on quality of life for new Multiple Myeloma patients. It involves assessing symptom relief and well-being using specific questionnaires like FACT-MM and HADS during the treatment process.See study design

What are the potential side effects?

Since this trial focuses on Palliative Care rather than direct medical treatments, side effects are not typical as in drug trials. However, emotional discomfort or distress from discussing symptoms or personal matters during assessments may occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can care for myself but may not be able to do heavy physical work.

Select...

I was diagnosed with symptomatic multiple myeloma less than 8 weeks ago.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months, 6 months, 9 months and 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months, 6 months, 9 months and 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months, 6 months, 9 months and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in QOL relative to baseline as measured by FACT-MM scores

Health services utilization as measured by number of ER visits, hospital admissions or ICU admissions

Number of PC visits made in the first 12 months after diagnosis

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Early Palliative Care IntegrationExperimental Treatment3 Interventions

12 months of PC with concurrent standard treatment for MM, QOL assessments

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Case Comprehensive Cancer CenterLead Sponsor

448 Previous Clinical Trials

31,365 Total Patients Enrolled

25 Trials studying Multiple Myeloma

1,705 Patients Enrolled for Multiple Myeloma

Renato Samala, MDPrincipal InvestigatorThe Cleveland Clinic

Media Library

Palliative Care (Palliative Care) Clinical Trial Eligibility Overview. Trial Name: NCT04248244 — N/A

Multiple Myeloma Research Study Groups: Early Palliative Care Integration

Multiple Myeloma Clinical Trial 2023: Palliative Care Highlights & Side Effects. Trial Name: NCT04248244 — N/A

Palliative Care (Palliative Care) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04248244 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities to become involved in the research project at this point?

"Affirmative. According to the details on clinicaltrials.gov, this experimental investigation is actively recruiting individuals. The trial was initially advertised on February 17th 2020 and has seen its most recent update October 20th 2022; it requires a total of 20 volunteers at one site."

Answered by AI

How many participants are being observed in this medical experiment?

"Yes, according to the information located on clinicaltrials.gov this research is actively accepting participants. This study was initially posted on February 17th 2020 and underwent its last edit October 20th 2022. The team behind it seeks a total of 20 patients from one site only."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Effects of Early Palliative Care Integration on Patients With Newly Diagnosed Multiple Myeloma

2020. "Effects of Early Palliative Care Integration on Patients With Newly Diagnosed Multiple Myeloma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04248244.